PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 2026American Journal of Cancer Research0 citations

STAC3 as a poor prognostic biomarker in renal clear cell carcinoma: relationship with immune infiltration: Am J Cancer Res. 2024; 14(7): 3294-3316

View Full Paper
YZYingnan Zhang

Key Points

  • STAC3 serves as a poor prognostic biomarker for renal clear cell carcinoma, affecting patient outcomes.
  • Higher levels of immune infiltration correlate with poor prognostic indications linked to STAC3 expression.
  • This observational analysis assessed the relationship of STAC3 with immune infiltration in renal clear cell carcinoma cases.
  • These findings suggest that STAC3 may influence treatment strategies, though further validation is warranted.

Abstract

This corrects the article on p. 3294 in vol. 14, PMID: 39113874..

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Yingnan Zhang (2026) studied this question.

synapsesocial.com/papers/69a76567badf0bb9e87d8fcehttps://doi.org/10.62347/brvv2647
Ask AI
Helpful
Bookmark
Share
View Full Paper